Susan K. Halstead
Serum anti‐GM2 and anti‐GalNAc‐GD1a ganglioside IgG antibodies are biomarkers for immune‐mediated polyneuropathies in cats
Halstead, Susan K.; Jackson, Mark; Bianchi, Ezio; Rupp, Stefan; Granger, Nicolas; Menchetti, Marika; Galli, Greta; Freeman, Paul; Kaczmarska, Adriana; Bhatti, Sofie F.M.; Brocal, Josep; José‐López, Roberto; Tipold, Andrea; Quintana, Rodrigo Gutierrez; Ives, Edward J.; Liatis, Theofanis; Nessler, Jasmin; Rusbridge, Clare; Willison, Hugh J.; Rupp, Angie
Authors
Mark Jackson
Ezio Bianchi
Stefan Rupp
Nicolas Granger
Marika Menchetti
Greta Galli
Paul Freeman
Adriana Kaczmarska
Sofie F.M. Bhatti
Josep Brocal
Roberto José‐López
Andrea Tipold
Rodrigo Gutierrez Quintana
Edward J. Ives
Theofanis Liatis
Jasmin Nessler
Clare Rusbridge
Hugh J. Willison
Angie Rupp
Abstract
Background and Aims
Recent work identified anti-GM2 and anti-GalNAc-GD1a IgG ganglioside antibodies as biomarkers in dogs clinically diagnosed with acute canine polyradiculoneuritis, in turn considered a canine equivalent of Guillain-Barré syndrome. This study aims to investigate the serum prevalence of similar antibodies in cats clinically diagnosed with immune-mediated polyneuropathies.
Methods
The sera from 41 cats clinically diagnosed with immune-mediated polyneuropathies (IPN), 9 cats with other neurological or neuromuscular disorders (ONM) and 46 neurologically normal cats (CTRL) were examined for the presence of IgG antibodies against glycolipids GM1, GM2, GD1a, GD1b, GalNAc-GD1a, GA1, SGPG, LM1, galactocerebroside and sulphatide.
Results
A total of 29/41 IPN-cats had either anti-GM2 or anti-GalNAc-GD1a IgG antibodies, with 24/29 cats having both. Direct comparison of anti-GM2 (sensitivity: 70.7%; specificity: 78.2%) and anti-GalNAc-GD1a (sensitivity: 70.7%; specificity: 70.9%) antibodies narrowly showed anti-GM2 IgG antibodies to be the better marker for identifying IPN-cats when compared to the combined ONM and CTRL groups (p=0.049).
Anti-GA1 and/or anti-sulphatide IgG antibodies were ubiquitously present across all sample groups, whereas antibodies against GM1, GD1a, GD1b, SGPG, LM1 and galactocerebroside were overall only rarely observed.
Interpretation
Anti-GM2 and anti-GalNAc-GD1a IgG antibodies may serve as serum biomarkers for immune-mediated polyneuropathies in cats, as previously observed in dogs and humans.
This article is protected by copyright. All rights reserved.
Citation
Halstead, S. K., Jackson, M., Bianchi, E., Rupp, S., Granger, N., Menchetti, M., Galli, G., Freeman, P., Kaczmarska, A., Bhatti, S. F., Brocal, J., José‐López, R., Tipold, A., Quintana, R. G., Ives, E. J., Liatis, T., Nessler, J., Rusbridge, C., Willison, H. J., & Rupp, A. (2022). Serum anti‐GM2 and anti‐GalNAc‐GD1a ganglioside IgG antibodies are biomarkers for immune‐mediated polyneuropathies in cats. Journal of the Peripheral Nervous System, https://doi.org/10.1111/jns.12529
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 23, 2022 |
Online Publication Date | Dec 27, 2022 |
Publication Date | Dec 27, 2022 |
Deposit Date | May 10, 2023 |
Publicly Available Date | May 10, 2023 |
Journal | Journal of the Peripheral Nervous System |
Print ISSN | 1085-9489 |
Electronic ISSN | 1529-8027 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1111/jns.12529 |
Keywords | Neurology (clinical); General Neuroscience |
Additional Information | Received: 2022-09-22; Accepted: 2022-12-23; Published: 2022-12-27 |
Files
Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats
(1.6 Mb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Version
VoR
You might also like
Dystonic head tremor in paroxysmal dyskinesia in 17 dogs (2021–2023)
(2023)
Journal Article
MRI findings in a cat with diffuse cerebellitis
(2023)
Journal Article
Bruxism in awake dogs as a clinical sign of forebrain disease: 4 cases
(2022)
Journal Article
Response to: Was the “alternating head tilt” “positioning head tilt”?
(2021)
Journal Article
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search